Site-specific m6A-miR-494-3p, not unmethylated miR-494-3p, compromises blood brain barrier by targeting tight junction protein 1 in intracranial atherosclerosis.

Autor: Woudenberg T; Department of Vascular Surgery, Leiden University Medical Center, Leiden, The Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands., van der Bent ML; Department of Vascular Surgery, Leiden University Medical Center, Leiden, The Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands., Kremer V; Department of Physiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC Location VUMc, Vrije Universiteit, Amsterdam, The Netherlands., Waas ISE; Department of Pathology, Amsterdam UMC, Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam, The Netherlands., Daemen MJAP; Department of Pathology, Amsterdam UMC, Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam, The Netherlands., Boon RA; Department of Physiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC Location VUMc, Vrije Universiteit, Amsterdam, The Netherlands.; Institute for Cardiovascular Regeneration, Centre for Molecular Medicine Goethe University, Frankfurt am Main, Germany.; German Center for Cardiovascular Research (DZHK), Frankfurt am Main, Germany., Quax PHA; Department of Vascular Surgery, Leiden University Medical Center, Leiden, The Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands., Nossent AY; Department of Vascular Surgery, Leiden University Medical Center, Leiden, The Netherlands.; Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.; Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark.

Publikováno v: British journal of pharmacology [Br J Pharmacol] 2024 Oct 17. Date of Electronic Publication: 2024 Oct 17.

Immunotherapy and Radiotherapy for Older Patients with Locally Advanced Non-Metastatic Non-Small-Cell Lung Cancer Who Are Not Candidates for or Decline Surgery and Chemotherapy: A Practical Proposal by the International Geriatric Radiotherapy Group.

Autor: Nguyen, Nam P.¹ (AUTHOR) satya.bose@howard.edu, Page, Brandi R.² (AUTHOR) brandi.page@gmail.com, Giap, Huan³ (AUTHOR) giap@uic.edu, Dahbi, Zineb⁴ (AUTHOR) dr.dahbizineb@gmail.com, Vinh-Hung, Vincent⁵ (AUTHOR) anhxang@gmail.com, Gorobets, Olena⁶ (AUTHOR) gorobets.helen@gmail.com, Mohammadianpanah, Mohammad⁷ (AUTHOR) mohpanah@gmail.com, Motta, Micaela⁸ (AUTHOR) motta.micaela@libero.it, Portaluri, Maurizio⁸ (AUTHOR) mportaluri@asst-pg23.it, Arenas, Meritxell⁹ (AUTHOR) meritxell.arenas@gmail.com, Bonet, Marta¹⁰ (AUTHOR) bonet.marta@gmail.com, Lara, Pedro Carlos¹¹ (AUTHOR) pedrocarlos.lara@ulpgc.es, Kim, Lyndon¹² (AUTHOR) lyndon.kim@mssm.edu, Dutheil, Fabien¹³ (AUTHOR) fabiendutheil.rth@gmail.com, Natoli, Elena^14,15 (AUTHOR) elenanatoli2@libero.it, Loganadane, Gokoulakrichenane¹⁶ (AUTHOR) gloganadane@yahoo.com, Lehrman, David¹⁷ (AUTHOR) lehrman.david@gmail.com, Bose, Satya¹ (AUTHOR) sarabjot.kaur@howard.edu, Kaur, Sarabjot¹ (AUTHOR), Blanco, Sergio Calleja¹⁸ (AUTHOR) seca@umich.edu

Publikováno v: Cancers. Sep2024, Vol. 16 Issue 17, p3112. 17p.

Epidemiology of Wegener's granulomatosis in northern Norway

Autor: W, Koldingsnes, H, Nossent

Publikováno v: Arthritis and rheumatism. 43(11)

To determine if changes in the incidence, prevalence, and clinical presentation of Wegener's granulomatosis (WG) have occurred in the stable population of northern Norway during a 15-year period.We performed a retrospective cohort study using hospita

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f258da2ba9bd7d748c6ccf962a4eb6d8
https://pubmed.ncbi.nlm.nih.gov/11083271

AB0885 Spondyloarthritis in rana, norway. Prevalence and subgroups

Autor: H. Nossent, I.M. Hansen, Øystein Førre

Publikováno v: Annals of the Rheumatic Diseases. 71:689.8-689

Background Spndyloarthritis is a relatively common rheumatic disease with prevalences ranging from 0,31% to 1,9% in different populations and investigated with different methods. Patients have inflammatory backpain or peripheral arthritis, enthesitis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4378a5e0f77f256b57f9665639baa036
https://doi.org/10.1136/annrheumdis-2012-eular.885

Diagnostic value of antibodies against ribosomal phosphoproteins. A cross sectional and longitudinal study

Autor: A, van Dam, H, Nossent, J, de Jong, J, Meilof, E J, ter Borg, T, Swaak, R, Smeenk

Publikováno v: The Journal of rheumatology. 18(7)

Antibodies against ribosomal phosphoproteins (anti-P antibodies) are found in about 10% of patients with systemic lupus erythematosus (SLE). Using an ELISA with a synthetic peptide for screening and an immunoblotting technique as a confirmation test

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ff6102f849e10e1ec7e5b9089fb04374
https://pubmed.ncbi.nlm.nih.gov/1920307